Skip to main content
. 2018 Jun 2;3(5):1110–1118. doi: 10.1016/j.ekir.2018.05.008

Table 5.

Clinical validation phase (phase 2): laboratory parameters (N = 529) cohort

Investigation Value (mean ± SD)
Hemoglobin (g/dl) 12.3 ± 3.3
HbA1c (%) 8.01 ± 3.1
Serum Albumin (g/l) 3.7 ± 1.4
Serum creatinine (mg/dl) 0.7 ± 0.7
eGFR (ml/min per 1.73 m2) 90 ± 38
Total cholesterol (mg/dl) 157 ± 70
LDL cholesterol (mg/dl) 83 ± 46
Triglycerides (mg/dl) 183 (149)

eGFR, estimated glomerular filtration rate; HbA1c, glycosylated hemoglobin; LDL, low-density lipoprotein.